CD74 antibody (Internal Region)
Quick Overview for CD74 antibody (Internal Region) (ABIN2613403)
Target
See all CD74 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- Internal Region
-
Purpose
- CD74
-
Sequence
- HSLEQKPTDA PPK
-
Specificity
- This antibody is expected to recognize isoform a (NP_001020330.1) and isoform b (NP_004346.1).
-
Cross-Reactivity
- Human
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Immunohistochemistry: Paraffin embedded Human Tonsil. Recommended concentration: 5 μg/mL.
Western Blot: Approx 33 kDa band observed in Human Tonsil lysates (calculated MW of 33.5 kDa according to NP_001020330.1). Recommended concentration: 0.01-0.03 μg/mL. Primary incubation was 1 hour. This antibody has been successfully used in WB: Meza-Romero
Peptide ELISA: antibody detection limit dilution 1:128000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- CD74 (HLA-DR-gamma (CD74))
-
Alternative Name
- CD74
-
Background
- CD74, DHLAG, HLADG, Ia-GAMMA, CD74 Molecule, major histocompatibility complex, class II invariant chain, CD74 antigen, CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated), HLA-DR-gamma, Ia-associated invar
-
Gene ID
- 972
-
NCBI Accession
- NP_001020330, NP_004346
-
Pathways
- Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Negative Regulation of intrinsic apoptotic Signaling, Cancer Immune Checkpoints
Target
-